Published in Infect Dis Ther on August 01, 2016
RSV Seasonality in Martinique in Children Aged 2 Years or Less (VRS-12) | NCT04415229
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease. Infect Dis Ther (2016) 0.79
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease. Infect Dis Ther (2016) 0.78
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease. Infect Dis Ther (2017) 0.77
The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood. Infect Dis Ther (2017) 0.76
Influenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methods. BMC Infect Dis (2017) 0.75
Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age. PLoS One (2017) 0.75
Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases. Infect Dis Ther (2017) 0.75
In vitro enhancement of RSV infection by maternal antibodies does not explain disease severity in infants. J Virol (2017) 0.75
Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England. Lancet Public Health (2017) 0.75
Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection. Hum Vaccin Immunother (2017) 0.75
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics (1998) 49.00
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86
The burden of respiratory syncytial virus infection in young children. N Engl J Med (2009) 8.95
Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA (1999) 8.07
Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child (1986) 7.39
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics (2004) 5.74
Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics (2014) 4.79
Viral etiology of severe pneumonia among Kenyan infants and children. JAMA (2010) 4.41
Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J Pediatr (2000) 4.08
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35
Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr (2003) 2.74
Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis (2000) 2.68
Incidence and severity of respiratory syncytial virus pneumonia in rural Kenyan children identified through hospital surveillance. Clin Infect Dis (2009) 2.22
Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. Epidemiol Infect (2002) 2.20
Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics (2013) 2.14
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J (2012) 2.12
Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics (2005) 2.03
Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics (2013) 1.83
High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax (2006) 1.72
Respiratory syncytial virus--United States, July 2007-June 2011. MMWR Morb Mortal Wkly Rep (2011) 1.71
Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics (2011) 1.70
Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics (2004) 1.58
Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics (2010) 1.55
Respiratory syncytial virus infection--risk factors for hospital admission: a case-control study. Acta Paediatr (2003) 1.53
Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child (2008) 1.51
Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties--2002-2009. Am J Epidemiol (2013) 1.50
The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child (2003) 1.49
The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years. Infection (2002) 1.45
Caesarean section and hospitalization for respiratory syncytial virus infection: a population-based study. Pediatr Infect Dis J (2015) 1.44
Detection of new respiratory viruses in hospitalized infants with bronchiolitis: a three-year prospective study. Acta Paediatr (2010) 1.42
Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr (2003) 1.39
Multiple simultaneous viral infections in infants with acute respiratory tract infections in Spain. J Clin Virol (2008) 1.39
Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J (2012) 1.34
Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection. Arch Dis Child (2004) 1.34
Epidemiology of respiratory syncytial virus infection requiring hospitalization in East Denmark. Pediatr Infect Dis J (1998) 1.29
Hospitalization for respiratory syncytial virus in the paediatric population in Spain. Epidemiol Infect (2003) 1.29
Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr (2002) 1.28
Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Pediatr Pulmonol (2002) 1.26
Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics. Eur J Pediatr (2007) 1.26
Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000. J Infect Dis (2003) 1.26
Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis. Eur J Clin Microbiol Infect Dis (2012) 1.25
Respiratory illness associated with influenza and respiratory syncytial virus infection. Arch Dis Child (2005) 1.22
A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life. Eur J Pediatr (2008) 1.21
Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr (2003) 1.19
Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS One (2014) 1.18
Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr (2004) 1.08
The burgeoning burden of respiratory syncytial virus among children. Infect Disord Drug Targets (2012) 1.07
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015. Vaccine (2015) 1.07
Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain. Epidemiol Infect (2006) 1.06
Burden of disease in hospitalized RSV-positive children in Germany. Klin Padiatr (2002) 1.06
Infant exposure to fine particulate matter and traffic and risk of hospitalization for RSV bronchiolitis in a region with lower ambient air pollution. Environ Res (2009) 1.05
Local variability in respiratory syncytial virus disease severity. Arch Dis Child (1997) 1.04
Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics (1999) 1.00
Respiratory viral infections during the 2009-2010 winter season in Central England, UK: incidence and patterns of multiple virus co-infections. Eur J Clin Microbiol Infect Dis (2012) 1.00
Readmission with respiratory syncytial virus (RSV) infection among graduates from a neonatal intensive care unit. Pediatr Pulmonol (2002) 0.98
Socioeconomic environmental factors and hospitalization for acute bronchiolitis during infancy. Acta Paediatr (2002) 0.98
Incidence of respiratory syncytial virus-positive hospitalizations in Germany. Eur J Clin Microbiol Infect Dis (2001) 0.97
Challenges and opportunities in developing respiratory syncytial virus therapeutics. J Infect Dis (2015) 0.96
Respiratory syncytial virus activity--United States, July 2011-January 2013. MMWR Morb Mortal Wkly Rep (2013) 0.96
Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection--results from a prospective multicenter German surveillance study. Int J Hyg Environ Health (2007) 0.96
Burden of respiratory syncytial viral infections on paediatric hospitals: a two-year prospective epidemiological study. Eur J Clin Microbiol Infect Dis (2002) 0.95
Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study. Adv Ther (2011) 0.94
Hospitalization for respiratory syncytial virus among California infants: disparities related to race, insurance, and geography. J Pediatr (2006) 0.94
Climatic factors and lower respiratory tract infection due to respiratory syncytial virus in hospitalised infants in northern Spain. Eur J Epidemiol (2005) 0.94
Virological and clinical characterizations of respiratory infections in hospitalized children. Ital J Pediatr (2013) 0.92
Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics (2006) 0.91
Family history of atopy and clinical course of RSV infection in ambulatory and hospitalized infants. Pediatr Pulmonol (2000) 0.91
Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece. Eur J Epidemiol (2003) 0.90
Eleven consecutive years of respiratory syncytial virus outbreaks in Croatia. Pediatr Int (2009) 0.90
Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants. Ital J Pediatr (2013) 0.89
Four year incidence of respiratory syncytial virus infection in infants and young children referred to emergency departments for lower respiratory tract diseases in Italy: the "Osservatorio VRS" Study (2000-2004). New Microbiol (2006) 0.88
Epidemiology of respiratory syncytial virus in children ≤2 years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study. Clin Epidemiol (2010) 0.88
Respiratory Syncytial Virus Bronchiolitis in Children up to 5 Years of Age in Spain: Epidemiology and Comorbidities: An Observational Study. Medicine (Baltimore) (2015) 0.88
Relative impact of influenza and respiratory syncytial virus in young children. Pediatrics (2009) 0.86
Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls. Pediatr Pulmonol (2010) 0.86
Effect of altitude on hospitalizations for respiratory syncytial virus infection. Pediatrics (2006) 0.86
RSV infection among children born moderately preterm in a community-based cohort. Eur J Pediatr (2014) 0.85
Bronchiolitis caused by respiratory syncytial virus in an area of portugal: epidemiology, clinical features, and risk factors. Eur J Clin Microbiol Infect Dis (2003) 0.85
Influenza A and respiratory syncytial virus hospital burden in young children in East London. Epidemiol Infect (2007) 0.84
Epidemiological and clinical features of respiratory viral infections in hospitalized children during the circulation of influenza virus A(H1N1) 2009. Influenza Other Respir Viruses (2011) 0.83
Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials. Influenza Other Respir Viruses (2015) 0.83
[Prospective regional study of an epidemic of respiratory syncytial virus (RSV) bronchiolitis]. Arch Pediatr (2002) 0.82
Decreased lung function precedes severe respiratory syncytial virus infection and post-respiratory syncytial virus wheeze in term infants. Eur Respir J (2014) 0.81
RSV frequency in children below 2 years hospitalized for lower respiratory tract infections. Turk J Pediatr (2013) 0.81
The seasonal variations of respiratory syncytial virus infections in Turkey: a 2-year epidemiological study. Turk J Pediatr (2012) 0.81
[Viral infection of the lower respiratory tract in hospitalized infants: etiology, clinical features and risk factors]. An Esp Pediatr (2001) 0.81
Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of a retrospective survey and evaluation of the validity of a medical information system programme. Epidemiol Infect (2011) 0.81
Risk Factors for Hospitalization for Respiratory Syncytial Virus Infection: A Population-based Cohort Study of Danish Children. Pediatr Infect Dis J (2016) 0.80
Bronchiolitis due to respiratory syncytial virus in hospitalized children: a study of seasonal rhythm. Acta Paediatr (2007) 0.80
[Incidence and cost of hospitalizations for bronchiolitis and respiratory syncytial virus infections in the autonomous community of Valencia in Spain (2001 and 2002)]. An Pediatr (Barc) (2006) 0.80
Outcome of the Respiratory Syncytial Virus related acute lower respiratory tract infection among hospitalized newborns: a prospective multicenter study. J Matern Fetal Neonatal Med (2015) 0.80
[Aetiology of bronchiolitis in hospitalised children in South-East Spain]. An Pediatr (Barc) (2011) 0.79
Viral coinfection in childhood respiratory tract infections. Arch Bronconeumol (2014) 0.79
Clinical evaluation of viral acute respiratory tract infections in children presenting to the emergency department of a tertiary referral hospital in the Netherlands. BMC Pediatr (2014) 0.78
Respiratory syncytial virus-associated hospitalizations in Louisiana. J La State Med Soc (2013) 0.78
Respiratory syncytial virus infection in a Sicilian pediatric population: risk factors, epidemiology, and severity. Allergy Asthma Proc (2008) 0.78
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease. Infect Dis Ther (2016) 0.79
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease. Infect Dis Ther (2016) 0.78
Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease. Infect Dis Ther (2017) 0.77
The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood. Infect Dis Ther (2017) 0.76
Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases. Infect Dis Ther (2017) 0.75